Literature DB >> 15121765

Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolism.

Alexandre Ghuysen1, Bernard Lambermont, Jean-Michel Dogné, Philippe Kolh, Vincent Tchana-Sato, Philippe Morimont, David Magis, Julien Hanson, Patrick Segers, Vincent D'Orio.   

Abstract

The aim of this study was to evaluate the effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane A2 synthase inhibitor and receptor antagonist, on the hemodynamic response to acute pulmonary embolism. Six anesthetized pigs were infused with placebo (placebo group) and compared with six other pigs receiving a continuous infusion of BM-573 (BM group). Pulmonary embolization with 0.3 g/kg autologous blood clots was carried out 30 min after the start of the infusion. Right ventricular pressure-volume loops were recorded using a conductance catheter, and end-systolic ventricular elastance was periodically assessed by varying right ventricular preload. Pulmonary vascular properties were studied by use of a four-element windkessel model. Hemodynamic data, including assessment of right ventricular-arterial coupling, were collected at baseline and every 30 min for 4 h. Blood samples were collected to assess gas exchange, thromboxane A2, and prostacyclin plasma levels and to evaluate platelet aggregation. Mean pulmonary arterial pressure in the placebo group increased significantly more than in the BM group, mainly because of an additional increase in pulmonary vascular resistance. Arterial and end-systolic ventricular elastances increased also more in the placebo group, whereas right ventricular efficiency decreased. BM-573 prevented both platelet aggregation induced by U-46619 (9,11-dideoxy-11alpha,9alpha-epoxymethanoprostaglandin F2alpha) or by arachidonic acid, and thromboxane A2 overproduction, whereas prostacyclin liberation was preserved. Oxygenation, however, was not significantly improved. We conclude that in this animal model of acute pulmonary embolism, infusion of BM-573 reduced pulmonary vasoconstriction. As a result, right ventricular-vascular coupling values were maintained at a maximal efficiency level.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121765     DOI: 10.1124/jpet.104.066852

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Computed tomographic pulmonary angiography and prognostic significance in patients with acute pulmonary embolism.

Authors:  A Ghuysen; B Ghaye; V Willems; B Lambermont; P Gerard; R F Dondelinger; V D'Orio
Journal:  Thorax       Date:  2005-08-30       Impact factor: 9.139

2.  Spiral computed tomographic pulmonary angiography in patients with acute pulmonary emboli and no pre-existing comorbidity: a prospective prognostic panel study.

Authors:  Reza Javadrashid; Maryam Mozayan; Mohammad Kazem Tarzamni; Mohammad Reza Ghaffari; Daniel F Fouladi
Journal:  Eur Radiol       Date:  2014-08-28       Impact factor: 5.315

3.  Acute pulmonary embolism decreases adenosine plasma levels in anesthetized pigs.

Authors:  François Kerbaul; Youlet By; Vlad Gariboldi; Choukri Mekkaoui; Pierre Fesler; Frédéric Collart; Serge Brimioulle; Yves Jammes; Jean Ruf; Régis Guieu
Journal:  ISRN Cardiol       Date:  2011-04-26

4.  Inherited trombophilic states and pulmonary embolism.

Authors:  Filip Konecny
Journal:  J Res Med Sci       Date:  2009-01       Impact factor: 1.852

5.  Effects of BM-573 on Endothelial Dependent Relaxation and Increased Blood Pressure at Early Stages of Atherosclerosis.

Authors:  Miguel Romero; Elvira Leon-Gomez; Irina Lobysheva; Géraldine Rath; Jean-Michel Dogné; Olivier Feron; Chantal Dessy
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.